Inventor · disambiguated record
David T. Scadden
Also filed as: SCADDEN DAVID · SCADDEN DAVID T
39 granted patents·37 pending applications·534 citations·filing 1993–2024
97Inventor score
Files withHARVARD COLLEGE21GEN HOSPITAL CORP16MASSACHUSETTS GEN HOSPITAL8SCADDEN DAVID T6BROAD INST INC4
Top patents by PatentIndex Score
76 records- 0195US7192769B2Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devicesCYTOMATRIX LLC·Filed 2002·Granted Mar 20, 2007·67 cites·53 claims
- 0295US6548299B1Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devicesFiled 2000·Granted Apr 15, 2003·72 cites·36 claims
- 0394US6448054B1Purposeful movement of human migratory cells away from an agent sourceGEN HOSPITAL CORP·Filed 2000·Granted Sep 10, 2002·103 cites·11 claims
- 0492US10280225B2Compositions and methods for non-myeloablative conditioningHARVARD COLLEGE·Filed 2016·Granted May 7, 2019·10 cites·25 claims
- 0591US5827742AMethod of selecting pluripotent hematopioetic progenitor cellsBETH ISRAEL HOSPITAL·Filed 1994·Granted Oct 27, 1998·85 cites·5 claims
- 0688US10570207B2Compositions and methods for non-myeloablative conditioningHARVARD COLLEGE·Filed 2018·Granted Feb 25, 2020·5 cites·15 claims
- 0788US7775469B2Purposeful movement of human migratory cells away from an agent sourceGEN HOSPITAL CORP·Filed 2006·Granted Aug 17, 2010·9 cites·17 claims
- 0886US7635477B2Parathyroid hormone receptor activation and stem and progenitor cell expansionGEN HOSPITAL CORP·Filed 2005·Granted Dec 22, 2009·6 cites·13 claims
- 0986US7141363B2Purposeful movement of human migratory cells away from an agent sourceGEN HOSPITAL CORP·Filed 2002·Granted Nov 28, 2006·20 cites·13 claims
- 1082US7943136B2Parathyroid hormone receptor activation and stem and progenitor cell expansionGEN HOSPITAL CORP·Filed 2009·Granted May 17, 2011·3 cites·14 claims
- 1182US5709858AAntibodies specific for Rse receptor protein tyrosine kinaseGENENTECH INC·Filed 1995·Granted Jan 20, 1998·30 cites·31 claims
- 1280US5677139AIn vitro differentiation of CD34+ progenitor cells into T lymphocytesHARVARD COLLEGE·Filed 1995·Granted Oct 14, 1997·59 cites·22 claims
- 1376US7176243B2CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesisBRIGHAM & WOMENS HOSPITAL·Filed 2001·Granted Feb 13, 2007·6 cites·9 claims
- 1475US12152080B2Compositions and methods for non-myeloablative conditioningHARVARD COLLEGE·Filed 2020·Granted Nov 26, 2024·0 cites·49 claims
- 1575US10906980B2Compositions and methods for non-myeloablative conditioningHARVARD COLLEGE·Filed 2019·Granted Feb 2, 2021·0 cites·30 claims
- 1674US11096934B2Compounds and methods useful for treating or preventing hematological cancersBROAD INST INC·Filed 2016·Granted Aug 24, 2021·1 cites·10 claims
- 1773US8088622B2P27 and P21 in gene therapiesSCADDEN DAVID T·Filed 2008·Granted Jan 3, 2012·0 cites·8 claims
- 1873US2025127929A1Scaffolds for modifying immune cells and the uses thereofHARVARD COLLEGE·Filed 2024·Application pending·0 cites
- 1970US11752238B2Recapitulating the hematopoietic niche to reconstitute immunityHARVARD COLLEGE·Filed 2017·Granted Sep 12, 2023·1 cites·22 claims
- 2070US8642569B2Methods for expansion of hematopoietic stem and progenitor cellsSCADDEN DAVID·Filed 2010·Granted Feb 4, 2014·2 cites·12 claims
- 2170US7462483B2p27 and p21 in gene therapiesGEN HOSPITAL CORP·Filed 2001·Granted Dec 9, 2008·3 cites·23 claims
- 2270US2024165302A1Recapitulating the hematopoietic niche to reconstitute immunityHARVARD COLLEGE·Filed 2023·Application pending·0 cites
- 2369US2024269252A1Compositions for inducing an immune responseHARVARD COLLEGE·Filed 2023·Application pending·0 cites
- 2467US7429383B2Parathyroid hormone receptor activation and hematopoietic progenitor cell expansionGEN HOSPITAL CORP·Filed 2003·Granted Sep 30, 2008·3 cites·10 claims
- 2562US8828965B2MiR-150 for the treatment of blood disordersGEN HOSPITAL CORP·Filed 2013·Granted Sep 9, 2014·0 cites·7 claims
- 2662US2009202493A1Mir-150 for the treatment of blood disordersGEN HOSPITAL CORP·Filed 2009·Application pending·0 cites
- 2762US2024018517A1Modulating hemataopoiesis and myleoid cell productionMASSACHUSETTS GEN HOSPITAL·Filed 2021·Application pending·0 cites
- 2861US7776334B2Parathyroid hormone receptor activation and hematopoietic progenitor cell expansionGEN HOSPITAL CORP·Filed 2008·Granted Aug 17, 2010·0 cites·23 claims
- 2961US6096527ANucleic acids encoding protein tryosine kinasesGENENTECH INC·Filed 1995·Granted Aug 1, 2000·10 cites·16 claims
- 3060US8530443B2miR-150 for the treatment of blood disordersLU JUN·Filed 2012·Granted Sep 10, 2013·0 cites·5 claims
- 3160US2022016106A1Compounds and methods useful for treating or preventing hematological cancersBROAD INST INC·Filed 2021·Application pending·0 cites
- 3260US2020206333A1Compositions for inducing an immune responseHARVARD COLLEGE·Filed 2019·Application pending·0 cites
- 3359US8802104B2Parathyroid hormone receptor activation and stem and progenitor cell expansionGEN HOSPITAL CORP·Filed 2012·Granted Aug 12, 2014·0 cites·9 claims
- 3457US12193996B2Monocyte compositions and methods for the treatment of infectious diseaseMASSACHUSETTS GEN HOSPITAL·Filed 2021·Granted Jan 14, 2025·0 cites·6 claims
- 3557US8309095B2Parathyroid hormone receptor activation and stem and progenitor cell expansionSCADDEN DAVID T·Filed 2011·Granted Nov 13, 2012·0 cites·5 claims
- 3657US7951364B2CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesisGEN HOSPITAL CORP·Filed 2006·Granted May 31, 2011·0 cites·10 claims
- 3757US2021214731A1Methods for treating cancerHARVARD COLLEGE·Filed 2020·Application pending·0 cites
- 3856US2014363449A1Methods, assays, and systems relating to saktGEN HOSPITAL CORP·Filed 2013·Application pending·0 cites
- 3955US6087144AProtein tyrosine kinasesGENENTECH INC·Filed 1995·Granted Jul 11, 2000·7 cites·10 claims
- 4055US2022143099A1Methods to enhance t cell regenerationMASSACHUSETTS GEN HOSPITAL·Filed 2020·Application pending·0 cites
- 4155US2012329153A1Car receptor as a mediator of migratory cell chemotaxis and/or chemokinesisPOZNANSKY MARK C·Filed 2011·Application pending·0 cites
- 4254US8461127B2p27 and p21 in gene therapiesSCADDEN DAVID T·Filed 2012·Granted Jun 11, 2013·0 cites·8 claims
- 4354US5965437AMethod of screening a compound for hematopoietic activityBETH ISRAEL HOSPITAL·Filed 1998·Granted Oct 12, 1999·14 cites·5 claims
- 4454US2023136218A1Methods and compositions for treating acute myeloid leukemiaHARVARD COLLEGE·Filed 2020·Application pending·0 cites
- 4553US7863044B2p18 in stem cell manipulationsCHENG TAO·Filed 2004·Granted Jan 4, 2011·0 cites·15 claims
- 4652US9750767B2IL-18 inhibition for promotion of early hematopoietic progenitor expansionMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Sep 5, 2017·0 cites·20 claims
- 4751US2021177880A1Methods and compositions for treating acute myeloid leukemiaHARVARD COLLEGE·Filed 2018·Application pending·0 cites
- 4850US2017131280A1Methods, assays, and systems relating to saktMASSACHUSETTS GEN HOSPITAL·Filed 2016·Application pending·0 cites
- 4949US2008112933A1Methods and Compositions for Increasing Stem Cell Homing Using Gas ActivatorsSCADDEN DAVID T·Filed 2005·Application pending·0 cites
- 5049US2016122405A1Homeodomain fusion proteins and uses thereofHARVARD COLLEGE·Filed 2014·Application pending·0 cites
Showing the top 50 of 76 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →